Hepatocellular Cancer Recruiting Phase 1 Trials for Spartalizumab (DB14892)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02947165Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.Treatment